Use of Atropine to Slow the Progression of Myopia: A Literature Review and Guidelines for Clinical Use

Abstract

Atropine 1% and various lower concentrations of atropine (0.5-0.01%) have been used to slow the progression of myopia. Cumulative data and meta-analysis from a number of studies have demonstrated that the most effective method for slowing the progression of myopia is atropine 1% instilled daily ( progression is slowed by almost 80%). Atropine’s side effects of mydriasis and cycloplegia have kept it from being prescribed more frequently. Recent studies have demonstrated that lower concentrations of atropine 0.025% to 0.01% are effective with significantly lower side effects. Discontinuing atropine treatment has displayed a rebound of myopia progression with higher amounts of rebound associated with higher atropine concentrations. Ocular side effects of atropine can be effectively managed with photochromic progressive lenses. In summary, atropine is not only safe, but it is also an effective drug to slow the progression of myopia.

Spectacles and orthokeratology lenses as non‑operative management in myopia: a brief review

“…Visual acuity is quite good, with the majority achieving 20/20 and over 90% achieving 20/30. The most significant complaints found with OK are halos secondary to the spherical aberration [48].…”